Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib

Conclusion: This is the first study in the literature showing that ezrin status is related with prognosis in patients with metastatic ccRCC.

Source: Journal of Cancer Research and Therapeutics - June 11, 2021 Category: Cancer & Oncology Authors: Bulent Cetin Ipek Isik Gonul Ozge Gumusay Baris Afsar Irem Bilgetekin Ahmet Ozet Aytug Uner Source Type: research